Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus

O. Brad Spiller, David J. Blackbourn, Linda Mark, David G. Proctor, Anna M. Blom*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

73 Citations (Scopus)

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is closely associated with Kaposi's sarcoma and certain B-cell lymphomas. The fourth open reading frame of the KSHV genome encodes a protein (KSHV complement control protein (KCP, previously termed ORF4)) predicted to have complement-regulating activity. Here, we show that soluble KCP strongly enhanced the decay of classical C3-convertase but not the alternative pathway C3-convertase, when compared with the host complement regulators: factor H, C4b-binding protein, and decay-accelerating factor. The equilibrium affinity constant (KD) of KCP for C3b and C4b was determined by surface plasmon resonance analysis to range between 0.47-10 μM and 0.025-6.1 μM, respectively, depending on NaCl concentration and cation presence. Soluble and cell-associated KCP acted as a cofactor for factor I (FI)-mediated cleavage of both C4b and C3b and induced the cleavage products C4d and iC3b, respectively. In the presence of KCP, FI further cleaved iC3b to C3d, which has never been described before as complement receptor 1 only mediates the production of C3dg by FI. KCP would enhance virus pathogenesis through evading complement attack, opsonization, and anaphylaxis but may also aid in targeting KSHV to one of its host reservoirs since C3d is a ligand for complement receptor 2 on B-cells.

Original languageEnglish
Pages (from-to)9283-9289
Number of pages7
JournalJournal of Biological Chemistry
Volume278
Issue number11
DOIs
Publication statusPublished - 14 Mar 2003

Bibliographical note

Acknowledgments
We thank Dr. Kevin Marchbank (University of Wales College of Medicine, Cardiff, UK) for guidance and discussion on C3dg studies, Profs. Patrick Moore and Yuan Chang (University of Pittsburgh Cancer Institute, Pittsburgh, PA) for valuable provision of resources and discussion, Dr. Bruno Villoutreix (University of Paris) for homology-based modeling, and Prof. B. Paul Morgan (University of Wales College of Medicine) and Prof. Björn Dahlbäck (Lund University, Malmö, Sweden) for continuous generous support.

Fingerprint

Dive into the research topics of 'Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus'. Together they form a unique fingerprint.

Cite this